The Effects of Chiropractic in Adults With Metabolic Syndrome
- Conditions
- Metabolic Syndrome
- Interventions
- Procedure: Chiropractic adjustment
- Registration Number
- NCT05884437
- Lead Sponsor
- Life University
- Brief Summary
The purpose of this study is to assess the feasibility of our study procedures/protocols and to look at the potential effects of chiropractic care on people with metabolic syndrome.
- Detailed Description
After providing informed consent, individuals will undergo 6 weeks of chiropractic care. Throughout these 6 weeks there will be three assessments (Day 0, Week 2, and Week 6) that each include the following:
1. Seated resting recording
2. Auditory oddball task
3. Isometric hand grip
4. Postural challenge
5. Treadmill walking
6. Patient-reported outcome surveys
Each assessment will consist of the following recordings:
1. Electroencephalography \[EEG\]
2. Electrodermal activity \[EDA\]
3. Impedance cardiography \[ICG\]
4. Electrocardiogram \[ECG\]
Recruitment & Eligibility
- Status
- SUSPENDED
- Sex
- All
- Target Recruitment
- 10
-
Individuals over the age of 18
-
Individuals who can wear an EEG net for 30 minutes
-
Individuals who can sit quietly for at least 15 minutes
-
Individuals who can walk unassisted for up to 10 minutes
-
Individuals who can provide informed consent
-
Individuals who meet 3 of the 5 following criteria:
- Elevated waist circumference (>40 in/102 cm if male and >35 in/88cm if female)
- Elevated triglycerides (>150 mg/dL) or drug treatment for elevated triglycerides
- Reduced HDL-cholesterol (<40mg/dL if male and <50 mg/dL if female) or drug treatment to increase HDL-C
- Elevated blood pressure (>130 mm Hg systolic BP or >85 mm Hg diastolic BP) or drug treatment to reduce blood pressure
- Elevated fasting glucose (>100 mg/dL) or drug treatment to reduce blood glucose
- Individuals with a known disorder resulting in syncope/fainting during postural changes (e.g., POTS, orthostatic hypotension)
- Individuals with impaired function of the dominant hand
- Individuals with malignant hypertension
- Individuals with a known heart condition such as arrhythmia that results in an aberrant ECG recording
- Individuals with any implanted devices (i.e., pacemakers)
- Individuals with brain aneurysms
- Individuals with a history of epilepsy or stroke that would influence EEG readings
- Individuals with a diagnosed externalizing or thought disorder (i.e., anti-social disorder, any major personality disorder such as borderline personality disorder, or schizophrenia)
- Individuals who are on short-acting benzodiazepines which include midazolam & triazolam
- Individuals with any serious injury or surgery to the head or torso, or lower body in the last 6 months
- Individuals with a hearing impairment or hearing aids (due to the auditory stimulus recording being performed)
- Individuals who are currently pregnant
- Individuals with current litigation related to a physical, health-related injury
- Individuals who have been diagnosed with rheumatoid arthritis, osteoporosis or instability of the neck.
- Individuals with moderate to severe pain on a daily basis
- Pain on the day of testing rated greater than 3/10 on a visual analog scale (VAS)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Chiropractic Chiropractic adjustment Chiropractic adjustment
- Primary Outcome Measures
Name Time Method Acceptability of treatment regimen for participants Week 6 9-item acceptability questionnaire
Recruitment rate through study completion, an average of 1 year Length of time needed to recruit target number of participants
Participant adherence rate through study completion, an average of 1 year Proportion of participants able to adhere to the testing \& treatment schedule
Participant retention rate through study completion, an average of 1 year Proportion of enrolled participants who complete the full testing regimen
Participant tolerability rate through study completion, an average of 1 year Proportion of participants able to perform all aspects of the testing regimen
- Secondary Outcome Measures
Name Time Method EEG resting state functional connectivity Week 6 64-channel hydronet cap
EEG evoked latency Week 6 64-channel hydronet cap during auditory oddball task
ECG respiratory sinus arrhythmia (RSA) Week 6 3 sensors on torso
Electrodermal activity (EDA) power spectral density (PSD) Week 6 2 sensors on first and second digits of non-dominant hand
Composite Autonomic Symptom Score COMPASS-31) Day 1 31-item questionnaire
EEG evoked amplitude Week 6 64-channel hydronet cap during auditory oddball task
skin conductance level (SCL) Week 6 2 electrodermal activity (EDA) sensors on first and second digits of non-dominant hand
ECG mean interbeat interval Week 6 3 sensors on torso
EEG resting state broadband power Week 6 64-channel hydronet cap
Composite Autonomic Symptom Score (COMPASS-31) Week 6 31-item questionnaire
Patient-Reported Outcomes Measurement Information System Cognitive Abilities and Cognitive Concerns Scale (PROMIS-Cog) Week 6 8-item questionnaire
Perceived Stress Scale (PSS) Week 6 10-item questionnaire
Impedance cardiogram (ICG) pre-ejection period (PEP) Week 6 2 sensors on chest and 2 sensors on back
ECG de-trended fluctuation analysis Week 6 3 sensors on torso
Impedance cardiogram (ICG) initial systolic time interval (ISTI) Week 6 2 sensors on chest and 2 sensors on back
Electrodermal activity (EDA) non-specific skin conductance responses (SCR) Week 6 2 sensors on first and second digits of non-dominant hand
Trial Locations
- Locations (1)
Dr. Sid E. Williams Center for Chiropractic Research
🇺🇸Marietta, Georgia, United States